134 related articles for article (PubMed ID: 22054072)
1. Rates of upgrade of ICD recipients to CRT in clinical practice and the potential impact of the more liberal use of CRT at initial implant.
Scott PA; Whittaker A; Zeb M; Watts E; Yue AM; Roberts PR; Morgan JM
Pacing Clin Electrophysiol; 2012 Jan; 35(1):73-80. PubMed ID: 22054072
[TBL] [Abstract][Full Text] [Related]
2. Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy.
Essebag V; Joza J; Birnie DH; Sapp JL; Sterns LD; Philippon F; Yee R; Crystal E; Kus T; Rinne C; Healey JS; Sami M; Thibault B; Exner DV; Coutu B; Simpson CS; Wulffhart Z; Yetisir E; Wells G; Tang AS
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):152-8. PubMed ID: 25417892
[TBL] [Abstract][Full Text] [Related]
3. The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.
van der Heijden AC; Borleffs CJ; Buiten MS; Thijssen J; van Rees JB; Cannegieter SC; Schalij MJ; van Erven L
Heart Rhythm; 2015 Jun; 12(6):1169-76. PubMed ID: 25749138
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ
J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504
[TBL] [Abstract][Full Text] [Related]
5. A Device Histogram-Based Simple Predictor of Mortality Risk in ICD and CRT-D Patients: The Heart Rate Score.
Wilkoff BL; Richards M; Sharma A; Wold N; Jones P; Perschbacher D; Olshansky B
Pacing Clin Electrophysiol; 2017 Apr; 40(4):333-343. PubMed ID: 28156008
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of ventricular arrhythmias in patients with cardiac resynchronization therapy without back-up ICD: a single-center experience.
Bortnik M; Degiovanni A; Dell'era G; Cavallino C; Occhetta E; Marino P
J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):301-6. PubMed ID: 23811840
[TBL] [Abstract][Full Text] [Related]
7. Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction.
McAlister FA; Ezekowitz J; Dryden DM; Hooton N; Vandermeer B; Friesen C; Spooner C; Rowe BH
Evid Rep Technol Assess (Full Rep); 2007 Jun; (152):1-199. PubMed ID: 17764218
[TBL] [Abstract][Full Text] [Related]
8. Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.
Jędrzejczyk-Patej E; Mazurek M; Kotalczyk A; Kowalska W; Konieczny-Kozielska A; Kozielski J; Podolecki T; Szulik M; Sokal A; Kowalski O; Kalarus Z; Średniawa B; Lenarczyk R
Europace; 2021 Jan; 23(1):113-122. PubMed ID: 33257952
[TBL] [Abstract][Full Text] [Related]
9. Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT-D.
Sebag FA; Lellouche N; Chen Z; Tritar A; O'Neill MD; Gill J; Wright M; Leclercq C; Rinaldi CA
J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1368-75. PubMed ID: 25066404
[TBL] [Abstract][Full Text] [Related]
10. Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer.
Landolina M; Curnis A; Morani G; Vado A; Ammendola E; D'onofrio A; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
Europace; 2015 Aug; 17(8):1251-8. PubMed ID: 25976906
[TBL] [Abstract][Full Text] [Related]
11. Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias.
Manfredi JA; Al-Khatib SM; Shaw LK; Thomas L; Fogel RI; Padanilam B; Rardon D; Vatthyam R; Gemma LW; Golden K; Prystowsky EN
Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):257-64. PubMed ID: 23443618
[TBL] [Abstract][Full Text] [Related]
12. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
Ermis C; Seutter R; Zhu AX; Benditt LC; VanHeel L; Sakaguchi S; Lurie KG; Lu F; Benditt DG
J Am Coll Cardiol; 2005 Dec; 46(12):2258-63. PubMed ID: 16360055
[TBL] [Abstract][Full Text] [Related]
13. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
Gadler F; Valzania C; Linde C
Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
[TBL] [Abstract][Full Text] [Related]
14. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of Implementation of QRS Characteristics in the Seattle Heart Failure Model in ICD and CRT-D Recipients.
VAN DER Heijden AC; Levy WC; VAN Erven L; Schalij MJ; Borleffs CJ
Pacing Clin Electrophysiol; 2016 Jun; 39(6):565-73. PubMed ID: 27027982
[TBL] [Abstract][Full Text] [Related]
17. Ampere Hour as a Predictor of Cardiac Resynchronization Defibrillator Pulse Generator Battery Longevity: A Multicenter Study.
Ellis CR; Dickerman DI; Orton JM; Hassan S; Good ED; Okabe T; Andriulli JA; Quan KJ; Greenspon AJ
Pacing Clin Electrophysiol; 2016 Jul; 39(7):658-68. PubMed ID: 26875541
[TBL] [Abstract][Full Text] [Related]
18. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
[TBL] [Abstract][Full Text] [Related]
19. [Predictors for need of antibradycardia and antitachycardia pacing after ICD implantation : Implications for the subcutaneous ICD].
Grett M; Christ M; Trappe HJ
Herzschrittmacherther Elektrophysiol; 2016 Dec; 27(4):390-395. PubMed ID: 27738753
[TBL] [Abstract][Full Text] [Related]
20. Manufacturer change and risk of system-related complications after implantable cardioverter defibrillator replacement: physicians' survey and data from the Detect Long-term Complications After Implantable Cardioverter Defibrillator Replacement Registry.
Biffi M; Menardi E; Narducci ML; Ammendola E; Messano L; Giofrè F; Baiocchi C; Saporito D; Lissoni F; Bertini M; Pierantozzi A; Zingarini G; Malacrida M; Ziacchi M
J Cardiovasc Med (Hagerstown); 2017 Dec; 18(12):968-975. PubMed ID: 29028784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
